R&D Systems™ Human IL-19 Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Manufacturer: R&D Systems™ 1035IL025
DescriptionThe Recombinant Human IL-19 Protein is derived from E. coli. The Recombinant Human IL-19 Protein has been validated for the following applications: Bioactivity.
|Reconstitute at 100μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein.|
|18 kDa (monomer)|
|>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.|
|E. coli-derived human IL-19 protein Leu25-Ala177,with an N-terminal Met|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok